Khosla Ventures led the genetic medicine developer's series A round, which comes after a 2015 seed round featuring Bloomberg Beta.

Pharmascience subsidiary Pendopharm has participated in Edesa Biotech's series A round as part of a licensing agreement.

Acute Care Solutions has participated in a $30.8m round for home care access platform DispatchHealth that was co-led by Questa Capital and Alta Partners.

Hearst has put $75m into M2Gen, a genetic database subsidiary of Moffitt Cancer Center, with a view to accelerating the development of cancer treatments.

The cardiovascular software developer has built modelling programs that could help doctors decide whether patients are fit for surgery.

University of Pittsburgh and accelerator BioMotiv are set to generate a spinout based on anti-inflammatory research by Rama Mallampalli and Beibei Chen.

Vertera Spine, a spinal implant developer base on Duke and Georgia Tech research, has been picked up shortly after receiving regulatory approval for two products.

The neurological disorder drug developer has secured $20m in a series B round backed by existing investors Johnson and Johnson and WuXi AppTec.

Diabetes treatment spinout Alms Therapeutics signed up Cap Innov'Est and Morningside Venture Capital as investors after previously tapping regional tech transfer office Satt Conectus for funding.